HDAC6 is a microtubule-associated deacetylase
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function. The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts. However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC6 catalyzes the deacetylation of K40 in the α-tubulin subunit of the microtubule,24 thereby regulating microtubule dynamics”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [24]
In the citing paper
“HDAC6, a tubulin deacetylase [24].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [24]
In the citing paper
“The histone deacetylase 6 (HDAC6) has also been implicated in tau deacetylation/acetylation [180].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [180]
In the citing paper
“HDAC6 was shown to be the deacetylase for a diverse set of substrates involved in tumourigenesis, such as HSP90, α-tubulin, cortactin and peroxiredoxins”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
In the citing paper
“HDAC6 knockout in mice does not lead to embryonic lethality”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 1×
“At least 11 proteins predicted to be members of the HDAC family have been identified on the basis of homology within the catalytic domai”
BackgroundPiperno, G., & Fuller, M. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.6.2085 · Cited by 757
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Self-citationMicrotubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation
Kaverina, I., Krylyshkina, O., & Small, J. V. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.1033 · Cited by 480
Histone acetylation: chromatin in action
Wade, P. A., Pruss, D., & Wolffe, A. P. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01016-5 · Cited by 471
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412 · cited 1×
“Unlike other family members, HDAC6 is uniquely resistant to the potent HDAC inhibitors trapoxin-B (TPXb”
BackgroundSelf-citationRegulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
Smith, D. S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M. J., Wynshaw-Boris, A., & Tsai, L.-H. (2000) · Nature Cell Biology · doi:10.1038/35041000 · Cited by 381
Cited by
Items 101–200 of 1,012
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
Miyake, Y., Keusch, J. J., Wang, L., Saito, M., Hess, D., Wang, X., Melancon, B. J., Helquist, P., Gut, H., & Matthias, P. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2140 · Cited by 315
Self-citationSelective Sirt2 inhibition by ligand-induced rearrangement of the active site
Rumpf, T., Schiedel, M., Karaman, B., Roessler, C., North, B. J., Lehotzky, A., Oláh, J., Ladwein, K. I., Schmidtkunz, K., Gajer, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7263 · Cited by 297
“These changes are not as pronounced when compared with the changes induced by the inhibition of the other main tubulin deacetylase KDAC6 (refs 38,39).”
Nonhistone protein acetylation as cancer therapy targets
Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S.-W. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.62 · Cited by 300
Acetylation of intrinsically disordered regions regulates phase separation
Saito, M., Hess, D., Eglinger, J., Fritsch, A. W., Kreysing, M., Weinert, B. T., Choudhary, C., & Matthias, P. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0180-7 · Cited by 300
Qian, D. Z., Kachhap, S. K., Collis, S. J., Verheul, H. M. W., Carducci, M. A., Atadja, P., & Pili, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4598 · Cited by 299
The Redox Basis of Epigenetic Modifications: From Mechanisms to Functional Consequences
Cyr, A. R., & Domann, F. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3492 · Cited by 297
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production
Ito, Y., Nakamura, S., Sugimoto, N., Shigemori, T., Kato, Y., Ohno, M., Sakuma, S., Ito, K., Kumon, H., Hirose, H., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.011 · Cited by 296
“On the other hand, our data suggest intracellular NRDC directly binds to tubulins (a4A-tubulin or b1-tubulin) (Figure 6C) and perhaps plays a role in tubulin conformation and remodeling by coordinating with HDAC6 (Figures 6E and 6F) (Hubbert et al., 2002; Miyake et al., 2016).”
HDAC6 Expression Is Correlated with Better Survival in Breast Cancer
Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y., Mita, K., Hamaguchi, M., Hayashi, S.-I., & Iwase, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0455 · Cited by 293
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Yamaguchi, T., Cubizolles, F., Zhang, Y., Reichert, N., Kohler, H., Seiser, C., & Matthias, P. (2010) · Genes & Development · doi:10.1101/gad.552310 · Cited by 291
“HDACs catalyze the deacetylation of lysine residues of histones as well as of an increasing number of other proteins, such as p53 (Luo et al. 2000), HSP90 (Bali et al. 2005; Kovacs et al. 2005), or a-tubulin (Hubbert et al. 2002; Zhang et al. 2003, 2008; for review, see Minucci and Pelicci 2006).”
BackgroundCaron, C., Boyault, C., & Khochbin, S. (2005) · BioEssays · doi:10.1002/bies.20210 · Cited by 291
Posttranslational modifications of tubulin and the polarized transport of kinesin-1 in neurons
Hammond, J. W., Huang, C.-F., Kaech, S., Jacobson, C., Banker, G., & Verhey, K. J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0044 · Cited by 281
“enhanced by trichostatin A (TSA) and tubacin, inhibitors of a known -tubulin deacetylase Histone Deacetylase 6 (HDAC6) (Hubbert et al., 2002; Matsuyama et al., 2002; Haggarty et al., 2003).”
The functional interactome landscape of the human histone deacetylase family
Joshi, P., Greco, T. M., Guise, A. J., Luo, Y., Yu, F., Nesvizhskii, A. I., & Cristea, I. M. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.26 · Cited by 289
The Control of HIV Transcription: Keeping RNA Polymerase II on Track
Ott, M., Geyer, M., & Zhou, Q. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.11.002 · Cited by 286
“HDAC6 is a mainly cytoplasmic class II HDAC known to deacetylate α-tubulin in cells (Hubbert et al., 2002).”
BackgroundPolyglutamine diseases: emerging concepts in pathogenesis and therapy
Shao, J., & Diamond, M. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm213 · Cited by 287
“tubulin (99) and Hsp90 (100)], and upregulate levels of heat shock proteins (e.”
BackgroundGodena, V. K., Brookes-Hocking, N., Moller, A., Shaw, G., Oswald, M., Sancho, R. M., Miller, C. C. J., Whitworth, A. J., & De Vos, K. J. (2014) · Nature Communications · doi:10.1038/ncomms6245 · Cited by 280
“Both the class IIb member HDAC6 and class III member SIRT2 have been shown to deacetylate α -tubulin 28,29 and conversely their inhibition increases microtubule acetylation.”
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
Tran, A. D.-A., Marmo, T. P., Salam, A. A., Che, S., Finkelstein, E., Kabarriti, R., Xenias, H. S., Mazitschek, R., Hubbert, C., Kawaguchi, Y., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03431 · Cited by 281
“Transwell chemotactic motility assay Procedures were as described (Hubbert et al., 2002; Malinda et al., 1999), except that, following 18 hours in serum-free DMEM, 2.5 105 cells were applied to each 12-well Transwell membrane insert or, in some experiments, 0.65 105 cells per 24- well Transwell insert (both having 8-…”
BackgroundMethodSelf-citationTan, T. Z., Miow, Q. H., Huang, R. Y., Wong, M. K., Ye, J., Lau, J. A., Wu, M. C., Bin Abdul Hadi, L. H., Soong, R., Choolani, M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201823 · Cited by 281
Colak, G., Xie, Z., Zhu, A. Y., Dai, L., Lu, Z., Zhang, Y., Wan, X., Chen, Y., Cha, Y. H., Lin, H., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031567 · Cited by 278
Ramalingam, S. S., Maitland, M. L., Frankel, P., Argiris, A. E., Koczywas, M., Gitlitz, B., Thomas, S., Espinoza-Delgado, I., Vokes, E. E., Gandara, D. R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9094 · Cited by 273
“HDAC 6, located in the cytoplasm, deacetylates tubulin by binding to the microtubule motor complex.(33) Preclinical studies have documented synergistic tubulin acetylation and subsequent mitotic arrest when cells were exposed to paclitaxel in combination with tubacin, a specific inhibitor of HDAC 6.”
BackgroundTDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies
Cohen, T. J., Lee, V. M. Y., & Trojanowski, J. Q. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.004 · Cited by 269
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Knutson, S. K., Chyla, B. J., Amann, J. M., Bhaskara, S., Huppert, S. S., & Hiebert, S. W. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.51 · Cited by 271
“Although HDACs have many non-histone protein targets for deacetylation (Juan et al, 2000; Luo et al, 2000; Ashburner et al, 2001; Hubbert et al, 2002; Shimazu et al, 2006; Gregoire et al, 2007), the disruption of liver metabolism was evident at the level of transcription and was accompa- nied by…”
BackgroundHDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons
Chen, S., Owens, G. C., Makarenkova, H., & Edelman, D. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010848 · Cited by 270
“Tubulin is a major substrate of HDAC6; inhibition of HDAC6 can dramatically increase the acetylation of tubulin both in vitro and in vivo [2,3].”
BackgroundHDAC6–p97/VCP controlled polyubiquitin chain turnover
Boyault, C., Gilquin, B., Zhang, Y., Rybin, V., Garman, E., Meyer‐Klaucke, W., Matthias, P., Müller, C. W., & Khochbin, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601210 · Cited by 267
“Its first identified physiological substrate was however the cytoplasmic protein a-tubulin (Hubbert et al, 2002; Matsuyama et al, 2002; Zhang et al, 2003).”
BackgroundPost-translational modifications of microtubules
Wloga, D., & Gaertig, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.063727 · Cited by 266
“Deacetylation of acetylK40 on -tubulin is catalyzed by HDAC6 (Hubbert et al., 2002; Matsuyama et al., 2002) and sirtuin 2 (SIRT2) (North et al., 2003) deacetylases, enzymes that are related to histone deacetylases.”
BackgroundQian, D. Z., Kato, Y., Shabbeer, S., Wei, Y., Verheul, H. M. W., Salumbides, B., Sanni, T., Atadja, P., & Pili, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1132 · Cited by 268
HDAC6 as privileged target in drug discovery: A perspective
Pulya, S., Amin, S. A., Adhikari, N., Biswas, S., Jha, T., & Ghosh, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105274 · Cited by 253
Li, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., Guo, J., Ling, E.-A., & Liang, F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4181-06.2007 · Cited by 265
“…might be that deacetylation lowered microtubule stability, reduced tubulin polymerization, increased depolymerization, or altered the binding of tubulin to associated proteins, as previously suggested in other cell types (Piperno et al., 1987; Robson and Burgoyne, 1989; Hubbert et al., 2002).”
BackgroundFinding the weakest link – exploring integrin-mediated mechanical molecular pathways
Roca-Cusachs, P., Iskratsch, T., & Sheetz, M. P. (2012) · Journal of Cell Science · doi:10.1242/jcs.095794 · Cited by 262
“Acetylation of a-tubulin stabilizes microtubules, which can regulate vesicular trafficking, autophagy or cell motility (Hubbert et al., 2002; Perdiz et al., 2011; Tran et al., 2007).”
BackgroundSchuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707362200 · Cited by 257
The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
Lee, Y.-S., Lim, K.-H., Guo, X., Kawaguchi, Y., Gao, Y., Barrientos, T., Ordentlich, P., Wang, X.-F., Counter, C. M., & Yao, T.-P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0188 · Cited by 260
“As Hsp90 requires HDAC6 for its full activity (21), inactivation of HDAC6 in cancer cells could affect oncogenic signaling, thereby inhibiting tumor growth.”
BackgroundSelf-citationGadadhar, S., Bodakuntla, S., Natarajan, K., & Janke, C. (2017) · Journal of Cell Science · doi:10.1242/jcs.199471 · Cited by 257
“HDAC6 controls the kinetics of platelet activation.”
InfluentialSaji, S., Kawakami, M., Hayashi, S.-I., Yoshida, N., Hirose, M., Horiguchi, S.-I., Itoh, A., Funata, N., Schreiber, S. L., Yoshida, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208646 · Cited by 258
“…Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc cell motility through the deacetylation of a-tubulin, indicating that HDAC6 is related to cell migration rather than to transcriptional regulation (Hubbert et al., 2002; Haggarty et al., 2003; Palazzo et al., 2003).”
BackgroundInfluentialSelf-citationTubulin acetylation: responsible enzymes, biological functions and human diseases
Li, L., & Yang, X.-J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2000-5 · Cited by 256
“As discussed above, it was reported that HDAC6-mediated tubulin deacetylation enhances microtubule-dependent motility and was proposed that this enhanced motility is due to reduced microtubule stability caused by decreased tubulin acetylation [60].”
InfluentialInoue, T., Hiratsuka, M., Osaki, M., Yamada, H., Kishimoto, I., Yamaguchi, S., Nakano, S., Katoh, M., Ito, H., & Oshimura, M. (2007) · Oncogene · doi:10.1038/sj.onc.1209857 · Cited by 258
“Moreover, HDAC6, another tubulin deacetylase (Hubbert et al., 2002), increases cell motility (Saji et al., 2005) and inhibits the clustering of CD3 in the central region of the immune synapse and of LFA-1 in the periphery by decreasing the acetylation of microtubules at contact regions (Serrador et…”
BackgroundHistone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3 + T-Regulatory Cells
de Zoeten, E. F., Wang, L., Butler, K., Beier, U. H., Akimova, T., Sai, H., Bradner, J. E., Mazitschek, R., Kozikowski, A. P., Matthias, P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05155-11 · Cited by 258
“deacetylation of cortactin (61), -tubulin (24), HSP90 (3, 27), and other proteins, including some, such as tubulin and cortactin, that affect cell migration (54).”
BackgroundTubulin acetylation and cell motility
Palazzo, A., Ackerman, B., & Gundersen, G. G. (2003) · Nature · doi:10.1038/421230a · Cited by 256
Microtubule detyrosination guides chromosomes during mitosis
Barisic, M., Silva e Sousa, R., Tripathy, S. K., Magiera, M. M., Zaytsev, A. V., Pereira, A. L., Janke, C., Grishchuk, E. L., & Maiato, H. (2015) · Science · doi:10.1126/science.aaa5175 · Cited by 256
Role for Histone Deacetylase 1 in Human Tumor Cell Proliferation
Senese, S., Zaragoza, K., Minardi, S., Muradore, I., Ronzoni, S., Passafaro, A., Bernard, L., Draetta, G. F., Alcalay, M., Seiser, C., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00494-07 · Cited by 254
“As expected by published data showing that HDAC6 is the major tubulin deacetylase and that HDAC1 has no specific tubulin deacetylase activity (25, 57), we did not observe changes in tubulin acetylation following siRNA-mediated knockdown of HDAC1 to HDAC3 (data not shown).”
BackgroundFernandes, I., Bastien, Y., Wai, T., Nygard, K., Lin, R., Cormier, O., Lee, H. S., Eng, F., Bertos, N. R., Pelletier, N., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00014-5 · Cited by 255
“HDAC6 is both cytoplasmic and nuclear, cation or LCoR and/or receptors will affect the relative and recent studies have revealed its capacity to deacet- affinities of LCoR and p160s for coactivator binding ylate tubulin (Hubbert et al., 2002), suggesting that it pockets.”
BackgroundTrotta, N., Orso, G., Rossetto, M. G., Daga, A., & Broadie, K. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.058 · Cited by 252
Caudo‐rostral brain spreading of α‐synuclein through vagal connections
Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250
Rational Therapeutic Combinations with Histone Deacetylase Inhibitors for the Treatment of Cancer
Thurn, K. T., Thomas, S., Moore, A., & Munster, P. N. (2011) · Future Oncology · doi:10.2217/fon.11.2 · Cited by 246
“Hubbert C, Guardiola A, Shao R, et al. HDAC6 is a microtubule-associated deacetylase.”
InfluentialSchroeder, T. M., Kahler, R. A., Li, X., & Westendorf, J. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403702200 · Cited by 244
Targeting histone deacetylase in cancer therapy
Lin, H., Chen, C., Lin, S., Weng, J., & Chen, C. (2006) · Medicinal Research Reviews · doi:10.1002/med.20056 · Cited by 241
“However, MS275 has been reported to be ineffective in inhibiting the a-tubulin acetylase HDAC 6, while TSA produced robust hyperacetylation of a-tubulin at sub-mM concentrations.(26) More recently, a small molecule, tabucin, has been identified, through high-throughput screening, to selectively inhibit HDAC 6-mediated…”
BackgroundRegulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6
Zilberman, Y., Ballestrem, C., Carramusa, L., Mazitschek, R., Khochbin, S., & Bershadsky, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.046813 · Cited by 239
αTAT1 is the major α-tubulin acetyltransferase in mice
Kalebic, N., Sorrentino, S., Perlas, E., Bolasco, G., Martinez, C., & Heppenstall, P. A. (2013) · Nature Communications · doi:10.1038/ncomms2962 · Cited by 241
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression
Yang, X.-J., & Seto, E. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00015-7 · Cited by 241
Stages of ciliogenesis and regulation of ciliary length
Avasthi, P., & Marshall, W. F. (2012) · Differentiation · doi:10.1016/j.diff.2011.11.015 · Cited by 234
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Table 1 Cilium Length Altering Proteins Functions to cilium length References Structural D2lic (Bonnafe et al., 2004) Klp-6 (Morsci and Barr, 2011) IFT…”
BackgroundInfluentialDe Vos, K. J., & Hafezparast, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.004 · Cited by 236
“, 2010), and deacetylation is mediated by histone deacetylase 6 (HDAC6) (Hubbert et al., 2002) and Sirtuin-2 (SIRT2) (North et al.”
InfluentialAnalysis of microtubule dynamic instability using a plus-end growth marker
Matov, A., Applegate, K., Kumar, P., Thoma, C., Krek, W., Danuser, G., & Wittmann, T. (2010) · Nature Methods · doi:10.1038/nmeth.1493 · Cited by 233
“We treated cells with trichostatin A, a broad-specificity histone deacetylase inhibitor that inhibits the tubulin-specific deacetylase HDAC6 (ref”
MethodAssembly and mechanosensory function of focal adhesions: experiments and models
Bershadsky, A. D., Ballestrem, C., Carramusa, L., Zilberman, Y., Gilquin, B., Khochbin, S., Alexandrova, A. Y., Verkhovsky, A. B., Shemesh, T., & Kozlov, M. M. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.11.001 · Cited by 235
Destaing, O., Saltel, F., Gilquin, B., Chabadel, A., Khochbin, S., Ory, S., & Jurdic, P. (2005) · Journal of Cell Science · doi:10.1242/jcs.02425 · Cited by 234
“This led us to identify a new Rho-dependent pathway in which the recently discovered microtubule acetylase HDAC6 (Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et al., 2003) was activated by Rho and its effector mDia2.”
BackgroundMethodChen, C.-S., Weng, S.-C., Tseng, P.-H., Lin, H.-P., & Chen, C.-S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505733200 · Cited by 231
Arts, J., King, P., Marin, A., Floren, W., Belin, A., Janssen, L., Pilatte, I., Roux, B., Decrane, L., Gilissen, R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0547 · Cited by 224
Hook, S. S., Orian, A., Cowley, S. M., & Eisenman, R. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172511699 · Cited by 224
Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications
Chin, L., Olzmann, J., & Li, L. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330692 · Cited by 227
Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials
Ma, X., Ezzeldin, H. H., & Diasio, R. B. (2009) · Drugs · doi:10.2165/11315680-000000000-00000 · Cited by 227
“a-Tubulin is the known substrate of HDAC6, and the deacetylation of a-tubulin is associated with cell motility([118]) and transforming growth factor-b1-induced epithelial-mesenchymal transition (EMT).”
InfluentialKnockdown of transactive response DNA‐binding protein (TDP‐43) downregulates histone deacetylase 6
Fiesel, F. C., Voigt, A., Weber, S. S., Van den Haute, C., Waldenmaier, A., Görner, K., Walter, M., Anderson, M. L., Kern, J. V., Rasse, T. M., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.324 · Cited by 226
“Functional depletion of the HDAC6 enzyme was shown by the concomitant increase of acetyl-tubulin (Figure 1D), a major cellular HDAC6 substrate (Hubbert et al, 2002).”
BackgroundRedox signalling directly regulates TDP‐43 via cysteine oxidation and disulphide cross‐linking
Cohen, T. J., Hwang, A. W., Unger, T., Trojanowski, J. Q., & Lee, V. M. Y. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.471 · Cited by 225
“Antibodies for western analysis were as follows: rabbit polyclonal anti-TDP-43 (Proteintech) 1:1000, mouse monoclonal antibody (mAb) anti-TDP-43 (Proteintech) 1:1000, rabbit polyclonal anti-TDP-43 C-terminal 1038 1:10,000, rabbit polyclonal anti-TDP-43 N-terminal 1065 1:10000, anti-GAPDH (6C5 mouse mAb; Advanced Immun…”
InfluentialHDACs and HDAC inhibitors in colon cancer
Mariadason, J. M. (2008) · Epigenetics · doi:10.4161/epi.3.1.5736 · Cited by 222
Conacci-Sorrell, M., Ngouenet, C., & Eisenman, R. N. (2010) · Cell · doi:10.1016/j.cell.2010.06.037 · Cited by 224
“Importantly, inhibiting the activity of the deacetylases HDAC6 and Sirt2 (known to deacetylate a-tubulin) generates augmented levels of acetylated a-tubulin and promotes differentiation of myoblasts (Iezzi et al., 2004).”
InfluentialIsothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity
Stimson, L., Rowlands, M. G., Newbatt, Y. M., Smith, N. F., Raynaud, F. I., Rogers, P., Bavetsias, V., Gorsuch, S., Jarman, M., Bannister, A., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0135 · Cited by 223
Histone deacetylase 10 promotes autophagy-mediated cell survival
Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300113110 · Cited by 221
“Numerous cytosolic and nuclear proteins are modified by posttranscriptional acetylation (18), including the proapoptotic protein, p53 (19); the macroautophagy regulator, α-tubulin (20); and the CMA chaperone protein, heat shock protein (Hsp)90 (21).”
BackgroundHistone Deacetylase 6 in Health and Disease
Seidel, C., Schnekenburger, M., Dicato, M., & Diederich, M. (2015) · Epigenomics · doi:10.2217/epi.14.69 · Cited by 217
Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
Singh, A. K., Bishayee, A., & Pandey, A. K. (2018) · Nutrients · doi:10.3390/nu10060731 · Cited by 221
“Acetylation also affects the activity of retinoblastoma protein (pRB) by blocking its cyclin E-cdk2 dependent phosphorylation so acetylation-dependent hypophosphorylation causes cell cycle arrest [26,27].”
BackgroundMolecular Basis for Age-Dependent Microtubule Acetylation by Tubulin Acetyltransferase
Szyk, A., Deaconescu, A. M., Spector, J., Goodman, B., Valenstein, M. L., Ziolkowska, N. E., Kormendi, V., Grigorieff, N., & Roll-Mecak, A. (2014) · Cell · doi:10.1016/j.cell.2014.03.061 · Cited by 218
“Acetylation is reversed in cells by the action of tubulin deacetylases such as HDAC6 and SIRT2 (Hubbert et al., 2002; North et al., 2003).”
Histone deacetylase inhibitors and cell death
Zhang, J., & Zhong, Q. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1656-6 · Cited by 214
“HDAC6 and Sirt2 are able to deacetylate α-tubulin and control the level of tubulin acetylation and assembly of the microtubule network [139, 140].”
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
Yao, W., Hu, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01918-w · Cited by 208
Self-citationLagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2669-2679.2003 · Cited by 216
“HDACs form a family of enzymes that catalyze the removal of acetyl moieties from acetylated proteins including histones, structural proteins, or transcription factors (25, 31).”
BackgroundHDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage
Kim, J. Y., Shen, S., Dietz, K., He, Y., Howell, O., Reynolds, R., & Casaccia, P. (2010) · Nature Neuroscience · doi:10.1038/nn.2471 · Cited by 214
“In addition, class II HDACs are cytosolic enzymes that remove acetyl groups from the epsilon positions of lysine residues of cytosolic proteins, including α-tubuli”
BackgroundHistone deacetylase inhibitors as therapeutics for polyglutamine disorders
Butler, R., & Bates, G. P. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1989 · Cited by 214
“In addition, HDAC6 deacetylates tubulin, microtubule”
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Wilson, A. J., Byun, D.-S., Nasser, S., Murray, L. B., Ayyanar, K., Arango, D., Figueroa, M., Melnick, A., Kao, G. D., Augenlicht, L. H., et al. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0139 · Cited by 214
“In contrast, the class I HDAC HDAC1 exhibited an exclusively nuclear staining pattern, whereas localization of the class IIb HDAC HDAC6 was predominantly cytoplasmic, consistent with previous studies (Hubbert et al., 2002; Waltregny et al., 2004).”
ResultThe regulation of SIRT2 function by cyclin-dependent kinases affects cell motility
Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Lüscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Knöll, B., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200707126 · Cited by 213
“Although the acetyl transferases that modify K40 are not known, two deacetylases that physically interact, SIRT2 and HDAC6, have been implicated in removing the modifi cation ( Hubbert et al., 2002 ; Dryden et al., 2003 ; North et al., 2003 ; Zhang et al., 2003 ).”
BackgroundAutophagy and microtubules - new story, old players
Mackeh, R., Perdiz, D., Lorin, S., Codogno, P., & Poüs, C. (2013) · Journal of Cell Science · doi:10.1242/jcs.115626 · Cited by 212
“The level of tubulin acetylation depends on the histone deacetylase HDAC6 and the NAD-dependent protein deacetylase sirtuin-2 (SIRT2) (Hubbert et al., 2002; North et al., 2003; Zhang et al., 2003), which have also been shown to active mTOR Lysosome Microtubules Omegasome Centrosome Nucleus Kinesins Kif1Bβ Kif2A Format…”
BackgroundInfluentialHistone Deacetylase 6 Regulates Growth Factor-Induced Actin Remodeling and Endocytosis
Gao, Y.-S., Hubbert, C. C., Lu, J., Lee, Y.-S., Lee, J.-Y., & Yao, T.-P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00393-07 · Cited by 209
“Overexpression of HDAC6 promotes cell motility, while pharmacological or genetic inactivation of HDAC6 inhibits it (17, 22) (Fig.”
BackgroundInfluentialSelf-citationMaxwell, M. M., Tomkinson, E. M., Nobles, J., Wizeman, J. W., Amore, A. M., Quinti, L., Chopra, V., Hersch, S. M., & Kazantsev, A. G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr326 · Cited by 207
The ins and outs of tubulin acetylation: More than just a post-translational modification?
Perdiz, D., Mackeh, R., Poüs, C., & Baillet, A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.014 · Cited by 208
Namdar, M., Perez, G., Ngo, L., & Marks, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013754107 · Cited by 203
“HDAC6 inhibition enhances α-tubulin acetylation, which stabilizes microtubules and is often associated with reduced cell movement (14).”
BackgroundDowling, M. L., Voong, K. R., Kim, M., Keutmann, M. K., Harris, E., & Kao, G. D. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1441 · Cited by 204
Chen, Y., Zhao, W., Yang, J. S., Cheng, Z., Luo, H., Lu, Z., Tan, M., Gu, W., & Zhao, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.019547 · Cited by 204
HDAC5 is a novel injury‐regulated tubulin deacetylase controlling axon regeneration
Cho, Y., & Cavalli, V. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.160 · Cited by 204
“Knockdown of HDAC4 or the class I HDACs did not prevent axotomy-induced microtubule deacetylation (Figure 5A; Supplementary Figure 7A–”
InfluentialHistone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2
Grégoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E., & Yang, X.-J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-06 · Cited by 203
“HDAC6 and SIRT2 efficiently deacetylate -tubulin acetylated on lysine 40 to regulate microtubule structure (32, 50).”
BackgroundHaggarty, S. J., Koeller, K. M., Wong, J. C., Butcher, R. A., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00095-4 · Cited by 201
Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models
Cao, Y., Semanchik, N., Lee, S. H., Somlo, S., Barbano, P. E., Coifman, R., & Sun, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911987106 · Cited by 200
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo
You, S.-H., Lim, H.-W., Sun, Z., Broache, M., Won, K.-J., & Lazar, M. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2476 · Cited by 199
Hsieh, T., Tsai, C., Hsu, C., Kuo, P., Lee, J., Chai, C., Wang, S., & Tsai, E. (2012) · The FASEB Journal · doi:10.1096/fj.11-191742 · Cited by 198
“bule-associated deacetylase protein (24) that enhances”
Blagosklonny, M. V., Robey, R. W., Sackett, D. L., Du, L., Traganos, F., Darżynkiewicz, Z., Fojo, T., & Bates, S. E. (2002) · PubMed · Cited by 199
Proteasomes Activate Aggresome Disassembly and Clearance by Producing Unanchored Ubiquitin Chains
Hao, R., Nanduri, P., Rao, Y., Panichelli, R. S., Ito, A., Yoshida, M., & Yao, T.-P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.016 · Cited by 197
“Aggresome clearance was also significantly inhibited by Trichostatin A (TSA), a pan-HDAC inhibitor that inactivates HDAC6 (Hubbert et al., 2002), whereas inhibitors targeting other HDAC members (MS275, sodium butyrate) had little effect.”
Self-citationHistone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation
Brunmeir, R., Lagger, S., & Seiser, C. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082649rb · Cited by 197
Waltregny, D., Glénisson, W., Tran, S. L., North, B. J., Verdin, E., Colige, A., & Castronovo, V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2303fje · Cited by 197
“This HDAC6 siRNA has been previously shown to efficiently silence HDAC6 expression (35).”
BackgroundClass IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
Kaluza, D., Kroll, J., Gesierich, S., Yao, T., Boon, R. A., Hergenreider, E., Tjwa, M., Rössig, L., Seto, E., Augustin, H. G., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.298 · Cited by 196
Self-citationDesign and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors
KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 192
Beckers, T., Burkhardt, C., Wieland, H., Gimmnich, P., Ciossek, T., Maier, T., & Sanders, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22751 · Cited by 192
Post‐translational modifications of tubulin in the nervous system
Fukushima, N., Furuta, D., Hidaka, Y., Moriyama, R., & Tsujiuchi, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06013.x · Cited by 193
“Reverse deacetylation is mediated by HDAC6 or SIRT2.”
BackgroundInfluentialHistone deacetylases and the immunological network: implications in cancer and inflammation
Villagra, A., Sotomayor, E. M., & Seto, E. (2010) · Oncogene · doi:10.1038/onc.2009.334 · Cited by 192
HDAC6 Deacetylase Activity Links the Tubulin Cytoskeleton with Immune Synapse Organization
Serrador, J. M., Cabrero, J. R., Sancho, D., Mittelbrunn, M., Urzainqui, A., & Sánchez-Madrid, F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00078-0 · Cited by 193
Ramalingam, S. S., Parise, R. A., Ramananthan, R. K., Lagattuta, T. F., Musguire, L. A., Stoller, R. G., Potter, D. M., Argiris, A. E., Zwiebel, J. A., Egorin, M. J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0162 · Cited by 193
Jenke, R., Reßing, N., Hansen, F. K., Aigner, A., & Büch, T. (2021) · Cancers · doi:10.3390/cancers13040634 · Cited by 180
Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice
Zhang, L., Liu, C., Wu, J., Tao, J.-J., Sui, X.-L., Yao, Z.-G., Xu, Y.-F., Huang, L., Zhu, H., Sheng, S.-L., et al. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140066 · Cited by 192
Hentchel, K. L., & Escalante-Semerena, J. C. (2015) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-15 · Cited by 191
Metadata
- Authors
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P.
- Affiliations
- Duke University (US)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Yao, Tso-Pang
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6887
- Pages
- 455-458
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2064959533
- Cited by
- 2,403
- References
- 21
- Citations by year
- 2026: 96 · 2025: 116 · 2024: 116 · 2023: 126 · 2022: 117 · 2021: 139 · 2020: 130 · 2019: 122 · 2018: 112 · 2017: 102 · 2016: 102 · 2015: 117 · 2014: 119 · 2013: 117 · 2012: 122
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Defense
- Damon Runyon Cancer Research Foundation
- World Bank Group
- Robert Bosch Stiftung
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC6, alpha-tubulin acetylation, microtubule stability, p150Glued, cell motility, chemotaxis, histone deacetylase
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Chemotaxis, Histone Deacetylases, Microtubule-Associated Proteins, Microtubules, Protein Binding, Tubulin, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.